Complete versus partial distal embolic protection during renal stenting--as good or as worse?
Thomas
T
Zeller
D000077284:Abciximab; D000800:Angioplasty, Balloon / Q000009:adverse effects* / Q000295:instrumentation*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012078:Renal Artery Obstruction / Q000628:therapy*; D051437:Renal Insufficiency / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab